Periodical (Journal)

  1. PSIthority
  2. Library
  3. Periodicals
ISSN  :   1557-1890 ( Print )   |   1557-1904 ( Online )   Active

Journal of Neuroimmune Pharmacology (JNIP)

Aim & Scope
The Journal of Neuroimmune Pharmacology (JNIP) is the peer-reviewed journal of the Society on NeuroImmune Pharmacology. JNIP interfaces the disciplines of immunology, pharmacology and experimental neuroscience by acting as a platform for research discoveries into the pathogenesis and pharmacology of nervous system disorders affecting the immune system and vice versa. Original interdisciplinary scientific contributions, concise "opinion," and broad reviews are welcome. Research areas reporting in JNIP include receptor cell signaling, the pathobiology, cognitive neuroscience, psychopharmacology and immunity of drugs of abuse, neurodegenerative disorders, neurovirology, neuroimmunology, and neuropharmacology. Manuscripts must include original research linked to the immunology and pharmacology of human neurologic and neuropsychiatric disorders including substance abuse, depression, psychosis, Alzheimer's and Parkinson's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, HIV-associated neurocognitive disorders, neuroendocrine and microbial infections, and immunological, toxic and metabolic disorders of the brain, spinal cord, and peripheral nerves. Topical studies of brain-immune interactions include, but are not limited to: (1) leukocyte trafficking into the nervous system; (2) innate immunity in the nervous system; (3) pathophysiology of neurodegenerative diseases; (4) effects of endogenous ligands on brain-immune interactions (neuronal-peripheral immune; neuronal-glial); (5) effects of drugs of abuse and other pharmacophores on peripheral immune responses, (6) medicinal chemistry and drug development; (7) vaccine approaches for neurologic and neuropsychiatric diseases; (8) bioimaging and proteomics; (9) nanomedicine; and (10) immune surveillance for microbial infections. JNIP will identify novel pharmacologic discoveries (organized action of drug targets, mechanisms, and development) of brain-immune interactions with a potential towards modifying the cellular and systemic responses that affect disease or lead to amelioration of brain injury and immune dysfunction. [1]

Go to Website

2023
19 RESULTS in 21 msec
2023-09-12
SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer's Disease.

N Sola-Sevilla , A Mesa-Lombardo , M Aleixo , ... , E Puerta

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 67
2023-09-04
The Endolysosomal Transporter DMT1 is Required for Morphine Regulation of Neuronal Ferritin Heavy Chain.

E Irollo , B Nash , J Luchetta , ... , O Meucci

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 44
not available
Curcumin-activated Olfactory Ensheathing Cells Improve Functional Recovery After Spinal Cord Injury by Modulating Microglia Polarization Through APOE/TREM2/NF-κB Signaling Pathway

C Jiang , Z Chen , X Wang , ... , D Hao

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 54
2023-09-08
PPARɑ Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer's Disease Defects By Inducing Autophagy in Mice Models.

S Krishnamoorthi , A Iyaswamy , SG Sreenivasmurthy , ... , M Li

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 55
2023-06-29
As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease.

PP Guan , TQ Ge , P Wang

Journal of Neuroimmune Pharmacology (JNIP) , 2023

  Review
0 118
not available
Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling Events

AM Johnson , S Jose , AR Palakkott , ... , H Saminathan

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 37
not available
Fatty Acid-Binding Protein 4 is Essential for the Inflammatory and Metabolic Response of Microglia to Lipopolysaccharide

Y Kagawa , YL Low , J Pyun , ... , JA Nicolazzo

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 44
not available
Natural Immunosuppressants as a Treatment for Chronic Insomnia Targeting the Inflammatory Response Induced by NLRP3/caspase-1/IL-1β Axis Activation: A Scooping Review

Z Aghelan , S Pashaee , SH Abtahi , ... , R Khodarahmi

Journal of Neuroimmune Pharmacology (JNIP) , 2023

  Review
0 77
2023-08-01
Characterization of Depression- and Anxiety-Like Behaviours in a Mouse Model of Relapsing-Remitting Multiple Sclerosis.

DS Peres , FT Viero , P Rodrigues , ... , G Trevisan

Journal of Neuroimmune Pharmacology (JNIP) , 2023

 
0 41
2023-06-30
Cyclophosphamide in the Treatment of Systemic Lupus Erythematosus-related Guillain-Barré Syndrome: A Systematic Review of Case Reports.

A Xiong , H Cui , R Deng , X Wei

Journal of Neuroimmune Pharmacology (JNIP) , 2023

  Review
0 29